Unusual 11 Mid-Day Movers 04/24: (ALIM) (TBOW) (ALGN) Higher; (BIG) (SANM) (NFLX) Lower
Tweet
Share
E-mail
Get Alerts ALIM Hot Sheet
Up)Join SI Premium – FREE
Alimera Sciences, Inc., (Nasdaq: ALIM) 26.8% HIGHER; today announced the Austrian Agency for Health and Food Safety (Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit, AGES) has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. Click here to see the full release.
Big Lots, Inc. (NYSE: BIG) 21.1% LOWER; now expect Q1 U.S. comparable store sales to be slightly negative compared to our prior guidance issued on March 2, 2012, which estimated a comparable store sales increase of 2% to 4%. U.S. comparable store sales were on plan through the first six weeks of the quarter; however, sales compared to plan began to slow in late March and trends have further softened as we moved through the month of April. From a merchandising perspective, furniture, hardlines, and seasonal, particularly lawn and garden, have been our best performing businesses; whereas, consumables and play n' wear, particularly electronics, are currently below expectations for the quarter. In terms of our recently acquired Canadian operations, based on results quarter-to-date, we anticipate retail sales for the first quarter of fiscal 2012 will be slightly above our guidance which estimated sales in the range of $25 to $30 million.
Trunkbow (Nasdaq: TBOW) 19.6% HIGHER; volume is extremely heavy today as technicians are pushing this stock 10 cents higher at a time.
Sanmina-SCI Corp (Nasdaq: SANM) 16.7% LOWER; reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.51 billion. Sanmina-SCI sees Q3 2012 EPS of $0.26 - $0.32, versus the consensus of $0.37.
Align Technology, Inc. (Nasdaq: ALGN) 15.3% HIGHER; reported Q1 EPS of $0.27, $0.06 better than the analyst estimate of $0.21. Revenue for the quarter came in at $135.1 million versus the consensus estimate of $128.05 million. Align Technology, Inc. sees Q2 2012 EPS of $0.26-$0.28, versus the consensus of $0.24.
Netflix, Inc. (Nasdaq: NFLX) 13.8% LOWER; reported Q1 EPS of ($0.08), $0.19 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $870 million versus the consensus estimate of $868.07 million. Sees Q2 revs of $873-$895M versus the consensus of $897.35M. Sees Q2 loss of $0.10 - to EPS of $0.14, versus the consensus of a loss of $0.17.
Otelco Inc. (Nasdaq: OTT) 13.6% LOWER; continuing lower from Monday after Time Warner (NYSE: TWC) said it wouldn't be renewing its contract with Otelco.
Kingold Jewelry (Nasdaq: KGJI) 13.5% HIGHER; pushing above resistance at $1.65. $1.80 seems to be serving as a new resistance level.
Affymax, Inc. (Nasdaq: AFFY) 11.9% HIGHER; Affymax and Takeda Pharmaceutical Company Limited, announced that OMONTYS (peginesatide) Injection is now available only for use in treating anemia due to chronic kidney disease (CKD) in adult patients on dialysis. OMONTYS is the only once-monthly erythropoiesis-stimulating agent (ESA) for anemia available to the dialysis patient population in the United States. OMONTYS is co-marketed by Affymax and Takeda Pharmaceuticals U.S.A. (TPUSA) and distributed by TPUSA.
Ceradyne, Inc. (Nasdaq: CRDN) 12.8% LOWER; reported Q1 EPS of $0.16, $0.21 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $106.3 million versus the consensus estimate of $120.08 million. Sees FY2012 EPS of $1.40-$1.65, versus prior guidance of $2.30-$2.65 and the consensus of $2.40. Sees FY2012 revenue of $540-$565 million, versus prior guidance of $590-$625 million and the consensus of $595.80 million.
Grifols (Nasdaq: GRFS) 12.1% HIGHER; reports Q1 net income of €67.5 million on sales of €666.7 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Big Lots, Inc. (NYSE: BIG) 21.1% LOWER; now expect Q1 U.S. comparable store sales to be slightly negative compared to our prior guidance issued on March 2, 2012, which estimated a comparable store sales increase of 2% to 4%. U.S. comparable store sales were on plan through the first six weeks of the quarter; however, sales compared to plan began to slow in late March and trends have further softened as we moved through the month of April. From a merchandising perspective, furniture, hardlines, and seasonal, particularly lawn and garden, have been our best performing businesses; whereas, consumables and play n' wear, particularly electronics, are currently below expectations for the quarter. In terms of our recently acquired Canadian operations, based on results quarter-to-date, we anticipate retail sales for the first quarter of fiscal 2012 will be slightly above our guidance which estimated sales in the range of $25 to $30 million.
Trunkbow (Nasdaq: TBOW) 19.6% HIGHER; volume is extremely heavy today as technicians are pushing this stock 10 cents higher at a time.
Sanmina-SCI Corp (Nasdaq: SANM) 16.7% LOWER; reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.51 billion. Sanmina-SCI sees Q3 2012 EPS of $0.26 - $0.32, versus the consensus of $0.37.
Align Technology, Inc. (Nasdaq: ALGN) 15.3% HIGHER; reported Q1 EPS of $0.27, $0.06 better than the analyst estimate of $0.21. Revenue for the quarter came in at $135.1 million versus the consensus estimate of $128.05 million. Align Technology, Inc. sees Q2 2012 EPS of $0.26-$0.28, versus the consensus of $0.24.
Netflix, Inc. (Nasdaq: NFLX) 13.8% LOWER; reported Q1 EPS of ($0.08), $0.19 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $870 million versus the consensus estimate of $868.07 million. Sees Q2 revs of $873-$895M versus the consensus of $897.35M. Sees Q2 loss of $0.10 - to EPS of $0.14, versus the consensus of a loss of $0.17.
Otelco Inc. (Nasdaq: OTT) 13.6% LOWER; continuing lower from Monday after Time Warner (NYSE: TWC) said it wouldn't be renewing its contract with Otelco.
Kingold Jewelry (Nasdaq: KGJI) 13.5% HIGHER; pushing above resistance at $1.65. $1.80 seems to be serving as a new resistance level.
Affymax, Inc. (Nasdaq: AFFY) 11.9% HIGHER; Affymax and Takeda Pharmaceutical Company Limited, announced that OMONTYS (peginesatide) Injection is now available only for use in treating anemia due to chronic kidney disease (CKD) in adult patients on dialysis. OMONTYS is the only once-monthly erythropoiesis-stimulating agent (ESA) for anemia available to the dialysis patient population in the United States. OMONTYS is co-marketed by Affymax and Takeda Pharmaceuticals U.S.A. (TPUSA) and distributed by TPUSA.
Ceradyne, Inc. (Nasdaq: CRDN) 12.8% LOWER; reported Q1 EPS of $0.16, $0.21 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $106.3 million versus the consensus estimate of $120.08 million. Sees FY2012 EPS of $1.40-$1.65, versus prior guidance of $2.30-$2.65 and the consensus of $2.40. Sees FY2012 revenue of $540-$565 million, versus prior guidance of $590-$625 million and the consensus of $595.80 million.
Grifols (Nasdaq: GRFS) 12.1% HIGHER; reports Q1 net income of €67.5 million on sales of €666.7 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
